Hematopoietic Stem Cell Transplantation (SCT) (DBCOND0041024)

Identifiers

Synonyms
HSCT therapy / Stem Cell Transplants / Hematopoietic Stem Cell Transplant / Stem Cell Transplant / Hematopoietic Stem Cell Transplant (HSCT) / Blood Stem Cell Transplant / Hematopoietic Stem Cell Transplantations / Stem Cell Transplantation, Hematopoietic / Hematopoietic Stem Cell Transplantation (HSCT) / Transplantation, Hematopoietic Stem Cell / Hematopoietic Stem Cell Transplantation / Transplantation of stem cell (procedure) / Stem Cell Transplantation / Hematopoietic stem cell infusion / Haematopoietic stem cell infusion / Hemopoietic stem cell transplant (procedure)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Abatacept
A disease-modifying antirheumatic drug (DMARD) used in the management of rheumatic conditions, such as rheumatoid or psoriatic arthritis, and for the prophylaxis of acute graft-versus-host disease.
Acyclovir
A guanosine analog used to treat herpes simplex, varicella zoster, herpes zoster.
Defibrotide
A mixture of single-stranded oligonucleotides used in the treatment of severe hepatic veno-occlusive disease with renal or pulmonary dysfunction following hematopoietic stem-cell transplantation.
Human cord blood hematopoietic progenitor cell
A set of stem cells derived from umbilical cord blood used for stem cell donation to unrelated recipients.
No drug targets
Micafungin
An antifungal agent used for the treatment of candidemia, acute disseminated candidiasis, and certain other invasive Candida infections, and for the prophylaxis of Candida infections during stem cell transplantation.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT03097796
A Multiple Ascending Dose Study of PUL-042 in Stem Cell Transplant RecipientsNo drug interventionsprevention1withdrawn
NCT05722210
Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell TransplantNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06496477
Light Therapy to Treat Depression in Pediatric Stem Cell Therapy RecipientsNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT04118530
Long Term Arrhythmia Risk and Cardiovascular Events in Hematopoietic Stem Cell TransplantNo drug interventionsNot AvailableNot Availablecompleted
NCT06328127
Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation SurvivorsNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT04853277
Patient Reported Outcomes and Patient Education in Cellular Therapy PatientsNo drug interventionspreventionNot Availablecompleted
NCT03613532
Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPNtreatment1recruiting
NCT03202849
A Randomized Trial of Vitamin D Supplementation With or Without Vitamin A in Stem Cell TransplantationNo drug interventionstreatmentNot Availablecompleted
NCT03039257
Vitamin A Replacement in Patients Undergoing HSCT and Its Role on MBI-LCBI RatesNo drug interventionstreatmentNot Availablecompleted
NCT06462365
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)No drug interventionsprevention1recruiting
NCT03759262
Ultra-high Dose Vitamin D for HSCTsupportive_care1completed
NCT02451462
Pilot Trial of Zoledronic Acid to Prevent Bone Loss in Hematopoietic Cell Transplant Recipientssupportive_careNot Availablewithdrawn
NCT03378089
Music Therapy and Hematopoietic Stem Cell TransplantNo drug interventionssupportive_careNot Availablecompleted
NCT03250546
Haploidentical and Mismatched Unrelated Donors Hematopoietic Stem Cell TransplantNo drug interventionstreatment2unknown_status
NCT06575712
Coping Skills Training for Symptom Management and Daily Steps (HCT Step Up)No drug interventionstreatmentNot Availablenot_yet_recruiting
NCT04549038
Time Restricted Nutrition in Pediatric Stem Cell Transplant RecipientsNo drug interventionsotherNot Availablecompleted
NCT01581164
Studies of the Immune Response to Vaccination After Hematopoietic Stem Cell TransplantationNot AvailableNot Availablecompleted
NCT05945121
Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell TransplantationNo drug interventionssupportive_careNot Availablerecruiting
NCT02982902
T Cell Therapy of Opportunistic Cytomegalovirus InfectionNo drug interventionssupportive_care0recruiting
NCT03737084
Effects of Compassion Training to Patients Undergoing HSCT on Biological and Psychosocial ParametersNo drug interventionssupportive_careNot Availablecompleted
NCT03509051
Prospective Study on the Vaccine Response to Meningococcal B Vaccine After Allogeneic Stem Cell TransplantationNo drug interventionspreventionNot Availablecompleted
NCT02350777
T-cell Depleted Hematopoietic Stem Cell Boosts Without Conditioning for Poor Marrow Graft Function Following Allogeneic Hematopoietic Stem Cell TransplantationNo drug interventionstreatment2terminated
NCT04263597
Oral Supplementation of 2'-Fucosyllactose in Allogeneic Bone Marrow Transplant Recipientsprevention1 / 2recruiting
NCT03886909
Impact of Prehabilitation in Oncology Via Exercise- Bone Marrow TransplantNo drug interventionspreventionNot Availablecompleted
NCT01504152
International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer CenterNo drug interventionsNot AvailableNot Availablecompleted
NCT02441075
70% Ethanol for Decontamination of CVL Exposed to Calcineurine Inhibitors Version 1.0, 1/9/2014No drug interventionstreatmentNot Availablecompleted
NCT01337648
Radiation Biodosimetry in Children Undergoing Total Body IrradiationNo drug interventionsNot AvailableNot Availablecompleted
NCT01215981
Influenza Vaccine Post Allogeneic TransplantpreventionNot Availableterminated
NCT04375579
Assessment of Elderly Undergoing Allogeneic Hematopoietic Stem Cell TransplantationNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03449953
Critical Care Outcomes of Hematologic Oncology PatientsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01070797
Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE)No drug interventionstreatment1completed
NCT01984671
Mobile Pain Coping Skills Training for Stem Cell Transplant PatientsNo drug interventionstreatmentNot Availablecompleted
NCT03641378
Inpatient Palliative Care for Patients Undergoing Hematopoietic Stem Cell TransplantationNo drug interventionstreatmentNot Availablecompleted
NCT04041219
Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patientstreatment4completed
NCT03259217
Clinical Application of Mesenchymal Stem Cells Seeded in Chitosan Scaffold for Diabetic Foot UlcersNo drug interventionstreatment1unknown_status
NCT03938324
Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic ConditionsNo drug interventionssupportive_careNot Availablecompleted
NCT01468935
Bone Marrow Cell Engraftment of the Uterus and Genetic Studies of Reproductive FunctioningNo drug interventionsNot AvailableNot Availablecompleted
NCT03859765
In Person and mHealth Coping Skills Training for Symptom Management and Steps in Stem Cell Transplant PatientsNo drug interventionstreatmentNot Availablecompleted
NCT03562065
Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical CordNo drug interventionstreatment1 / 2unknown_status
NCT04506320
Novel Drugs After Allo-HSCT in Patients With Multiple MyelomaNo drug interventionsNot AvailableNot Availablecompleted
NCT00760227
Testing the Effectiveness of Child and Parent-Targeted Health Promotion Interventions in Pediatric Stem Cell TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT02177760
Sirolimus Prophylaxis for aGVHD in TME SCIDprevention2withdrawn
NCT02225145
Fertility Preservation in Women Who Will Have Gonadotoxic Therapy or Hematopoetic Stem Cell Transplantation, and in Women With Sickle Cell DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT05515497
BMT4me: Post-HSCT Medication Adherence mHealth AppNo drug interventionssupportive_careNot Availablerecruiting
NCT06155188
Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood LeukemiaNo drug interventionstreatmentNot Availablerecruiting
NCT02652052
Hematopoietic Stem Cell Transplant Survivors Studysupportive_careNot Availablerecruiting
NCT04610359
Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial CystitisNo drug interventionstreatment1unknown_status
NCT04922970
Strength Training as Prevention and Treatment of Late Effects in Long-term Survivors of Pediatric HSCT.No drug interventionspreventionNot Availableunknown_status
NCT05775718
Shingrix In Recipients of Allogeneic Transplantstreatment2recruiting
NCT00656058
Montelukast to Treat Bronchiolitis Obliteranstreatment2completed
NCT01189786
Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-SelectionNo drug interventionstreatmentNot Availablerecruiting
NCT04589286
Randomized Study of Digital Life Coaching in Myeloma Patients Undergoing TransplantationNo drug interventionssupportive_careNot Availablecompleted
NCT05712148
Spheroidal Mesenchymal Stem Cells in Retinitis PigmentosaNo drug interventionssupportive_care1 / 2completed
NCT04219657
Comparison Between Skin Graft Versus Skin Graft and Stem Cell ApplicationNo drug interventionstreatment1completed
NCT04997473
Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant PatientsNo drug interventionsotherNot Availablerecruiting
NCT06075927
Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCTNo drug interventionstreatment1 / 2not_yet_recruiting
NCT01092195
Gardasil Vaccination in Post Stem Cell Transplant Patientstreatment1completed
NCT03440775
Digital Stories and Psychosocial Wellbeing in Stem Cell Transplant PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT05524246
Pravastatin as a Prophylactic to Reduce Endothelial Injury in Pediatric Patients With Elevated Body Mass Indexprevention1recruiting
NCT02626715
Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDStreatment2completed
NCT04908735
Ruxolitinib for Early Lung Dysfunction After Hematopoietic Stem Cell Transplanttreatment2recruiting
NCT04098445
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04712435
Efficacy of N-acetylcysteine Versus Placebo as Prophylaxis of Sinusoidal Obstruction Syndrome in Patients Undergoing Hematopoietic Stem Cell Transplantationprevention2unknown_status
NCT03710031
Developing Self-Management Interventions After HCTNo drug interventionsNot AvailableNot Availablecompleted
NCT00275678
Comparison of Peripheral Blood Stem Cell Transplantation With Bone Marrow Transplantation for the Treatment of Serious Hematological MalignanciesNo drug interventionstreatment3completed
NCT03959007
Impact of Supportive Care on the Experience of Hospitalization of Patients Staying in the Protected Area of the Department of Blood DiseasesNo drug interventionssupportive_careNot Availablerecruiting
NCT00682799
Serial Analysis of Chimerism in Patients With Refractory Cytopenia (RC) Transplanted With Reduced Intensity Conditioning (RIC)No drug interventionsNot AvailableNot Availablecompleted
NCT04808167
Remote Ischemic Conditioning in HSCTNo drug interventionsdevice_feasibilityNot Availablecompleted
NCT02414113
Study for the Evaluation of a GVHD Negative Outcome Score (GNOS) in Matched Unrelated or Haploidentical Hematopoietic Stem Cell TransplantNo drug interventionsNot AvailableNot Availablecompleted
NCT02577939
Evaluation of Cardiorespiratory Performance After Interval Exercise Training Prior to Hematopoietic Cell TransplantationNo drug interventionstreatmentNot Availablecompleted
NCT02083731
MSC for Treatment of CMV InfectionNo drug interventionstreatment2unknown_status
NCT01457040
Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic LeukemiaNo drug interventionstreatment2 / 3completed
NCT02574897
The Ability of Electronic Patient Symptom Reporting to Reduce Symptom Burden During Hospitalization for ChemotherapyNo drug interventionshealth_services_researchNot Availablecompleted
NCT02083718
Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft FunctionNo drug interventionstreatment2unknown_status
NCT01763086
Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell TransplantNo drug interventionstreatment2unknown_status
NCT02240992
MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet EngraftmentNo drug interventionstreatment2 / 3unknown_status
NCT04818957
Vitamin D Replacement Using Oral Thin Film (OTF) Cholecalciferol in Patients Undergoing Hematopoietic Stem Cell TransplantationNo drug interventionstreatmentNot Availablecompleted
NCT02641236
Gut Decontamination In Pediatric Allogeneic Hematopoieticprevention2completed
NCT05185817
Effectiveness of COVID-19 Vaccine in Hematopoietic Stem Cell Transplant PatientsNo drug interventionsprevention2unknown_status
NCT04691622
Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised HostsNo drug interventionstreatment1recruiting
NCT05947864
Monitoring of Measles-specific Immune Status in Adult Allogeneic Hematopoietic Stem Cell Transplant RecipientsNo drug interventionsotherNot Availablerecruiting
NCT01501708
Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infectiontreatment2unknown_status
NCT06639750
Respiratory Microbioma and Respiratory Complications After Hematopoietic Stem Cell TransplantionNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03654599
Effects of Digital Stories Intervention on Psychosocial Well-beingNo drug interventionssupportive_careNot Availablecompleted
NCT03000244
Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell TransplantationNo drug interventionsNot AvailableNot Availablerecruiting
NCT04503213
A Study to Assess CSF1R-related Leukoencephalopathy After Stem Cell TransplantationNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT05027945
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrometreatment2recruiting
NCT05436418
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantationtreatment1 / 2recruiting
NCT05441670
Art and Physical Therapy in Pediatric HCTNo drug interventionssupportive_careNot Availablerecruiting
NCT05605574
Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell TransplantNo drug interventionssupportive_careNot Availablerecruiting
NCT05940961
Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALLtreatment2recruiting
NCT06599346
Effects of Mesenchymal Stem Cell Supernatant on Prevention and Treatment of Skin/Mucosal Injury in Hematology PatientsNo drug interventionstreatmentNot Availablerecruiting
NCT00000603
Cord Blood Stem Cell Transplantation Study (COBLT)No drug interventionstreatment2completed
NCT02474290
Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AMLtreatment2 / 3completed
NCT02677987
The "Light for the Brain" StudyNo drug interventionstreatmentNot Availablecompleted
NCT03862833
Zoledronic Acid in Combination With Interleukin-2 to Expand Vγ9Vδ2 T Cells After T-replete Haplo-identical Allotransplanttreatment1completed
NCT02763033
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT PatientsNo drug interventionsprevention2recruiting
NCT03279133
Ledipasvir/Sofosbuvir Treatment for Hepatitis C in HCT Recipients.treatment4withdrawn
NCT04690933
AntiCMV molécules Monitoring in Real-life in Stem Cell RecipientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04945954
Pharmacokinetic Study of Post-transplant Cyclophosphamide in Pediatric PatientsNo drug interventionspreventionNot Availableunknown_status
NCT06118853
Impact of Yoga and Gentle Massage Practices on Symptom Management in Patients Undergoing HSCTNo drug interventionssupportive_careNot Availablerecruiting
NCT02791347
Nutrition Intervention Among Stem Cell Recipients: Post Hospital DischargeNo drug interventionssupportive_careNot Availablecompleted
NCT01728545
The Collection and Storage of Umbilical Cord Blood for TransplantationNo drug interventionsNot AvailableNot Availablerecruiting
NCT05290545
Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCTNo drug interventionstreatment3completed
NCT00731705
In-Vitro Studies in Depletion of Haplotype Mismatched Alloreactive T CellsNo drug interventionsNot AvailableNot Availablewithdrawn
NCT04635397
Immunomonitoring After Hematopoietic Stem Cell TransplantationNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06125483
TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCTNo drug interventionstreatmentNot Availablerecruiting
NCT04496011
Effect of the Cycloergometer in Patients Undergoing Hematopoietic Stem Cell TransplantationNo drug interventionstreatmentNot Availableunknown_status
NCT03037671
Evaluation of Malglycemia Via Continuous Glucose Monitoring in the Pediatric HSCT PopulationNo drug interventionsNot AvailableNot Availablecompleted
NCT02600988
Immunomodulatory Effect of Vitamin D in Allogenic Post-transplantprevention1 / 2completed
NCT03019809
A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patientstreatment2unknown_status
NCT04092309
Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow TransplantationpreventionNot Availableunknown_status
NCT05634915
Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell TransplantationNo drug interventionstreatment4recruiting
NCT05583175
Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignanciestreatment2recruiting
NCT00179075
Repository: Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell TransplantNo drug interventionsNot AvailableNot Availablecompleted
NCT01763099
Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft FailureNo drug interventionstreatment2unknown_status
NCT05656599
Immune Reconstitution to CMV After HSCT: Impact of Clinical Factors and Therapy StrategiesNot AvailableNot Availableenrolling_by_invitation
NCT00179049
Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell TransplantNo drug interventionsNot AvailableNot Availablecompleted
NCT06484049
Prospective Observational Clinical Study on Changes in Cognitive Levels in Elderly Patients Before and After Hematopoietic Stem Cell TransplantationNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01255449
Respiratory Impedance and Obliterative BronchiolitisdiagnosticNot Availablecompleted
NCT00582036
Glucose Control In Hematopoetic Stem Cell TransplanttreatmentNot Availableterminated
NCT06525519
Comparison of Different Dose of Anti-T Lymphocyte Globulin (ATLG) in Haploidentical HSCT for GVHD ProphylaxisNo drug interventionstreatment3not_yet_recruiting
NCT03225417
Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease.treatment1 / 2active_not_recruiting
NCT06198517
Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCTNo drug interventionspreventionNot Availablerecruiting
NCT04937634
Pharmacokinetic Study of Melphalan in Pediatric Hematopoietic Stem Cell Transplantationtreatment1recruiting
NCT01194934
NOX-A12 Multiple Ascending Dose Study in Healthy Volunteerstreatment1completed
NCT00115258
Nutrition Support in Pediatric Stem Cell TransplantationNo drug interventionstreatment3completed
NCT02564458
Fitness in Allogeneic Stem Cell TransplantationNo drug interventionstreatmentNot Availablecompleted
NCT03842735
Physical Activity in Children During Hematopoietic Stem Cells Transplantation (HSCT)No drug interventionssupportive_careNot Availablecompleted
NCT02206035
A Study of Tacrolimus/Methotrexate and Tocilizumab to Prevent Acute Graft-Versus-Host Disease (AGVD) After Allogeneic Hematopoietic Stem Cell Transplantprevention2completed
NCT02663622
Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002)treatment2completed
NCT05362630
Infliximab Efficacy, TDM and Serum TNFα Levels in Pediatric HSCT Recipients With aGVHD: Prospective Observational StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02312830
Belgian Cross-sectional Allogeneic Transplant Survivor StudyNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT00460330
Evaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCTNo drug interventionsNot AvailableNot Availableunknown_status
NCT00148148
A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantationtreatment2completed
NCT01714557
Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell TransplantationpreventionNot Availableunknown_status
NCT05696457
Effects of Music Therapy in Controlling Symptoms in Patients With AML and Undergoing HSCTNo drug interventionssupportive_careNot Availablecompleted
NCT01916057
Hepatosplenic CANdidiasis : PETscan and Immune Response AnalysisNo drug interventionsdiagnosticNot Availablecompleted
NCT05681026
Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United StatesNo drug interventionssupportive_careNot Availablerecruiting
NCT05675826
The Impact of Donor COVID-19 Infection Status on the Recipient in Allo-HSCTNo drug interventionsNot AvailableNot Availablerecruiting
NCT06241274
Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCTNo drug interventionstreatmentNot Availablerecruiting
NCT04788420
Influence of Co-existing Mutations on Sorafenib Maintenance Therapy After Allo-HSCT for Patients With FLT3-ITD AMLNot AvailableNot Availablecompleted
NCT03324620
Effectiveness Rehabilitation Hematopoietic Transplantation (ovERsHOT)No drug interventionspreventionNot Availablecompleted
NCT00674882
Protocol For Collecting Long-Term Follow-Up Data On Recipients of Bone Marrow and Blood Stem Cell TransplantNo drug interventionsNot AvailableNot Availablecompleted
NCT06423131
Prospective Clinical Trial for Children With TCRαβ Depleted vs Traditional Haplo Identicle HSCTNo drug interventionstreatmentNot Availablerecruiting
NCT02543073
MSC for Treatment of Interstitial Lung Disease After Allo-HSCTNo drug interventionstreatment1 / 2unknown_status
NCT01432873
Oral Selenium Therapy for the Prevention of Mucositistreatment1 / 2unknown_status
NCT06003660
Brain Neuronal Networks, Chemosensory and Trigeminal Functions in Allo-HSCTNo drug interventionsNot AvailableNot Availablerecruiting
NCT06102694
Identification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic MicroangiopathyNo drug interventionsNot AvailableNot Availablerecruiting
NCT03106662
Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Hematological Malignanciestreatment3completed
NCT01883180
ATG in Haploidentical HSCT for Acute Graft-versus-host Disease ProphylaxisNo drug interventionstreatment4completed
NCT00029380
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemiatreatment2completed
NCT01135589
Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantationprevention4unknown_status
NCT00563589
Mycophenolate Mofetil for the Prophylaxis of Graft-versus-host Disease in High Risk Allogeneic Stem Cell TransplantationpreventionNot Availableunknown_status
NCT02390544
A Pharmacokinetic Study of Melphalan in Childrenbasic_science1completed
NCT00959140
Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Related DonorsNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT03575767
Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCTNo drug interventionsNot AvailableNot Availablecompleted
NCT01018446
Hematopoietic Stem Cell Transplantation Based on Pharmacokinetic and Pharmacodynamic Modelingtreatment1completed
NCT06021210
Letermovir for the Prevention of CMV Infection in HSCT Recipients Based on the Outcome of mNGStreatment2recruiting
NCT03915210
Physical Inactivity in Candidates of HSCTNo drug interventionsNot AvailableNot Availablecompleted
NCT02412423
Post-transplantation Cyclophosphamide for Haploidentical Transplant From Maternal or Collateral Donorsprevention4completed
NCT00509938
Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant Recipientsprevention1 / 2completed
NCT02983643
Body Composition Changes During Stem Cell Transplantation: The Case Of Lymphoma PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT04786002
Target Busulfan Exposure in Children With HSCT in ChinaNot AvailableNot Availableunknown_status
NCT04298502
The Molecular Mechanism of CMV-driven NKG2C+NK Cell Expansion in HumanNo drug interventionsNot AvailableNot Availableunknown_status
NCT03014102
Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantationprevention1 / 2unknown_status
NCT03007602
Effects of Upper Extremity Aerobic Exercise Training in Hematopoietic Stem Cell Transplantation RecipientsNo drug interventionssupportive_careNot Availablecompleted
NCT03010579
Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantationtreatment4unknown_status
NCT06564233
RCT Supportive Care Outpatient RIC HCTNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT05528354
Venetoclax and Decitabin Based Conditioning Regimen Followed With Post-HSCT Decitabin Maintenance Therapy in TP53 Mutant AML/MDS PatientsNo drug interventionstreatment0recruiting
NCT04869254
Lymphocyte Count, ATG Dose and Incidence and Severity of GVHD in Pediatric Recipients of HSCTNo drug interventionsNot AvailableNot Availablecompleted
NCT02327351
TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PIDNo drug interventionstreatment2 / 3completed
NCT00948753
Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantationtreatment1 / 2completed
NCT00402753
Ambulatory Physical Exercise Program in Hematopoietic Stem Cell Transplantation RecipientsNo drug interventionssupportive_care0completed
NCT01353677
Feasibility of Collecting Quality of Life Data in Collaboration With the Stem Cell Therapeutic Outcomes DatabaseNo drug interventionsNot AvailableNot Availablecompleted
NCT06082947
αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT)No drug interventionstreatmentNot Availablerecruiting
NCT03136445
TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopeniasupportive_care3completed
NCT04674345
Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute Leukemiatreatment2 / 3unknown_status
NCT02241005
Theraworx Bath Wipes Versus Standard Bath Wipes in the Reduction of Vancomycin-Resistant EnterococciNo drug interventionspreventionNot Availablecompleted
NCT06554197
Evaluation of CMV/EBV-CMI in Haploid HSCTNo drug interventionsNot AvailableNot Availablerecruiting
NCT05855083
Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMAtreatment2recruiting
NCT00766883
Problem-Solving Education for Caregivers and Patients During Stem Cell TransplantNo drug interventionstreatment2completed
NCT05667428
A Multicenter Open-label Clinical Study on the Prevention of Premature Ovarian Failure After HSCTpreventionNot Availablenot_yet_recruiting
NCT00029393
Induction of Stable Chimerism for Sickle Cell AnemiaNo drug interventionstreatment2completed
NCT01598688
Cyclosporine (CSA) Level in Blood Samples Collected From Different LinesNo drug interventionsdiagnosticNot Availablecompleted
NCT01711788
Intrabone Infusion of Umbilical Cord Blood Stem CellsNo drug interventionstreatment2completed
NCT00701688
Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantationtreatment1completed
NCT02799888
Maraviroc-Based GVHD Prophylaxis in HLA-Unrelated and HLA-Mismatched Related Transplantationprevention2unknown_status
NCT05789615
Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in ChinaNot AvailableNot Availablerecruiting
NCT03616015
Dysbiosis and Immune Reconstitution After Allo-HSCTNo drug interventionsbasic_scienceNot Availableunknown_status
NCT06071637
Low Power Laser Therapy As Prevention Of Oral Mucositis And Oropharyngeal Pain In Patients Undergoing Allogenetic HSCTNo drug interventionsprevention3recruiting
NCT04822532
Precision Dosing of Busulfan in Children Undergoing HSCTNo drug interventionstreatmentNot Availablerecruiting
NCT05355675
The Association of Microbiota Composition With cGVHD After Allo-HSCTNo drug interventionsNot AvailableNot Availablerecruiting
NCT02326675
Cryotherapy in the Prevention of Chemotherapy-Induced Mucositis in Stem Cell TransplantNo drug interventionssupportive_careNot Availableterminated
NCT01714570
Piperacillin/Tazobactam for Empirical Therapy of Febrile NeutropeniatreatmentNot Availablecompleted
NCT04146870
Nutritional Status of Patients After Hematopoietic Stem Cell TransplantationNo drug interventionsNot AvailableNot Availablerecruiting
NCT04535570
Evolution of the Energy Expenditure During Hematopoietic Stem Cell TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT03263442
High Dose Intravenous Thiamine for the Prevention of Delirium in Allogeneic Hematopoietic Stem Cell Transplantationprevention2completed
NCT05151406
Myths and Misconceptions About HSCT in a Limited Resource RegionNo drug interventionshealth_services_researchNot Availablecompleted
NCT03727113
Optimization of Antibiotic Treatment in Hematopoietic Stem Cell ReceptorsNo drug interventionsNot AvailableNot Availablecompleted
NCT02512718
Safety and Tolerability of Intravenous Fish Oil Lipid Emulsion in Children Undergoing Hematopoietic Cell Transplantationsupportive_care1completed
NCT04428918
Biospecimen Procurement for Immunological Landscape Studies Following Hematopoietic Cell TransplantationNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03719534
Haplo HCT vs Haplo-cord HCT for Patients With AMLNo drug interventionstreatment3completed
NCT00888316
Iron Overload in Patients Undergoing Donor Stem Cell TransplantNo drug interventionsNot AvailableNot Availablecompleted
NCT03803696
Multimodal Sexual Dysfunction Intervention In HCTNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT03515096
Eltrombopag vs. rhTPO to Increase Platelet Level After HSCTtreatment3completed
NCT04095858
Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005)treatment3terminated
NCT03625063
Effects of Pulmonary Rehabilitation in Hematopoietic Stem Cell Transplantation RecipientsNo drug interventionsscreeningNot Availablecompleted
NCT04942886
Prophylactic Entecavir for HBV Reactivation in Past HBV Infected Patients With Hematopoietic Stem Cell TransplantationtreatmentNot Availableenrolling_by_invitation
NCT04868786
Pharmacokinetics and Pharmacodynamics of Mycophenolate Mofetil in Pediatric Hematopoietic Stem Cell Transplantationprevention1recruiting
NCT02683525
Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantationtreatment2completed
NCT00023530
Blood and Marrow Transplant Clinical Research NetworkpreventionNot Availablecompleted
NCT04275830
The Effects of Heart Rate Variability Biofeedback Training on Hematopoietic Cell Transplantation PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT00067730
A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantationtreatment4completed
NCT02319226
Toward Immune Biomarkers for Tolerance and GvHD in HumansNo drug interventionsNot AvailableNot Availableunknown_status
NCT03689465
PTCy-ATG vs ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxisprevention4unknown_status
NCT02535182
Pilot Study Using Propranolol To Promote Prenylation Of Gtpase Rap1b In Hematopoietic Stem Cell Transplant RecipientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00948727
Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell Transplantationprevention2completed
NCT04580576
Gender Differences in Pediatric Hematopoietic Stem Cell Transplantation (HSCT)No drug interventionsNot AvailableNot Availablecompleted
NCT01873794
Treating Cancer-Related Fatigue Through Systematic Light ExposureNo drug interventionssupportive_careNot Availablecompleted
NCT00582894
Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological DiseasestreatmentNot Availablecompleted
NCT05150080
Early Identification and Evaluation of Cyclophosphamide CardiotoxicityNo drug interventionsNot AvailableNot Availableunknown_status
NCT02643589
Dose Study of Antithymocyteglobulin in Haploidentical Allogeneic Stem Cell TransplantationNo drug interventionspreventionNot Availableunknown_status
NCT06339892
HCMV Breakthrough Infections During Letermovir ProphylaxisNo drug interventionsdiagnosticNot Availablerecruiting
NCT05929092
TFBC Combined With UCBT in the Treatment of High-risk Malignant Hematological DiseasesNo drug interventionstreatmentNot Availablerecruiting
NCT05904067
A Study to Evaluate the Safety and Efficacy of COVID-19 Convalescent Plasma (CCP) Transfusion to Prevent COVID-19 in Adult Recipients Following Hematopoietic Stem Cell TransplantationpreventionNot Availablerecruiting
NCT01061801
Spouses/Partners Expressing Their Thoughts After TransplantNo drug interventionsbasic_scienceNot Availablecompleted
NCT05131412
Mesenchymal Stem Cells for the Treatment of Pneumonia Post Haematopoietic Stem Cell TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT06148610
Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and SupportNo drug interventionsNot AvailableNot Availablerecruiting
NCT01274195
Hematopoietic Stem Cell Transplantation With Targeted Busulfan and Fludarabine in Pediatric AMLtreatment2unknown_status
NCT06494423
Employment Support After Hematopoietic Stem Cell TransplantationNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT06385808
Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AMLtreatmentNot Availablenot_yet_recruiting
NCT04203108
ATG in HLA-matched Sibling HSCT as GVHD Prophylaxistreatment4unknown_status
NCT00563108
Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell TransplantationtreatmentNot Availableunknown_status
NCT02398708
Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCTNo drug interventionsNot AvailableNot Availablecompleted
NCT02673008
MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCTNo drug interventionsprevention2 / 3completed
NCT04976699
CD24Fc for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005)treatment3active_not_recruiting
NCT02401009
Protocol for a Research Database for HCT, Other Cellular Therapies and Marrow Toxic InjuriesNo drug interventionsNot AvailableNot Availableactive_not_recruiting